2017 - Competency KM-D: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
|- | |- | ||
|} | |} | ||
Additionally, incoming care transmissions can be received in PCC EHR via a continuity of care document (C-CDA) and [http://learn.pcc.com/help/direct-secure-messaging/#Reconcile_a_C-CDA_Document medications can be reconciled from this document]. | |||
=KM 15 (Core): Maintains an up-to-date list of medications for more than 80 percent of patients= | =KM 15 (Core): Maintains an up-to-date list of medications for more than 80 percent of patients= | ||
| Line 37: | Line 39: | ||
|} | |} | ||
=KM 16 (1 Credit): Assesses understanding and provides education, as needed, on new prescriptions for more than 50 percent of patients/families/caregiver= | |||
The practice uses patient-centered methods, such as open-ended questions (i.e., teach-back collaborative method), to assess patient understanding. Educational materials are designed with regard to patient need (e.g., reading level). Lack of understanding, due to low health literacy or communication barriers, leads to poorer health outcomes and compromises patient safety. | |||
=KM 17 (1 Credit): Assesses and addresses patient response to medications and barriers to adherence for more than 50 percent of patients, and dates the assessment= | |||
The practice asks patients if they are having difficulty taking a medication, are experiencing side effects and are taking the medication as prescribed. If a patient is not taking a medication as prescribed, the practice determines why. | |||
=KM 18 (1 Credit): Reviews controlled substance database when prescribing relevant medications= | |||
The practice consults a state controlled-substance database—also known as a Prescription Drug Monitoring Program (PDMP) or Prescription Monitoring Program (PMP)—before dispensing Schedule II, III, IV and V controlled substances. | |||
=KM 19 (2 Credits): Systematically obtains prescription claims data in order to assess and address medication adherence= | |||
The practice systematically obtains prescription claims data or other medication transaction history. This may include systems such as SureScripts e-prescribing network, regional health information exchanges, insurers or prescription benefit management companies. The practice uses prescription claims data to determine whether a patient is adhering to the medication treatment plan. | |||
Latest revision as of 16:27, 14 August 2017
Competency D: The practice addresses medication safety and adherence by providing information to the patient and establishing processes for medication documentation, reconciliation and assessment of barriers.
KM 14 (Core): Reviews and reconciles medications for more than 80 percent of patients received from care transitions
| Description | Example/Screenshot/Documentation | Source | Date Added |
|---|---|---|---|
| In PCC EHR, a component called "Transition of Care (ARRA)" can be added to protocols. The first check box adds the patient to the denominator, the second check box adds them to the numerator. The result is reported from the EHR Modified Stage 2 MU report as the "Medication Reconciliation" measure. |  |
PCC EHR | 08/14/17 |
Additionally, incoming care transmissions can be received in PCC EHR via a continuity of care document (C-CDA) and medications can be reconciled from this document.
KM 15 (Core): Maintains an up-to-date list of medications for more than 80 percent of patients
| Description | Example/Screenshot/Documentation | Source | Date Added |
|---|---|---|---|
| Refer to the "Medication List" measure in the Stage 1 MU Reports in PCC EHR. To meet this measure, patients need to either have an active medication or an indication that they take no medications. |
KM 16 (1 Credit): Assesses understanding and provides education, as needed, on new prescriptions for more than 50 percent of patients/families/caregiver
The practice uses patient-centered methods, such as open-ended questions (i.e., teach-back collaborative method), to assess patient understanding. Educational materials are designed with regard to patient need (e.g., reading level). Lack of understanding, due to low health literacy or communication barriers, leads to poorer health outcomes and compromises patient safety.
KM 17 (1 Credit): Assesses and addresses patient response to medications and barriers to adherence for more than 50 percent of patients, and dates the assessment
The practice asks patients if they are having difficulty taking a medication, are experiencing side effects and are taking the medication as prescribed. If a patient is not taking a medication as prescribed, the practice determines why.
KM 18 (1 Credit): Reviews controlled substance database when prescribing relevant medications
The practice consults a state controlled-substance database—also known as a Prescription Drug Monitoring Program (PDMP) or Prescription Monitoring Program (PMP)—before dispensing Schedule II, III, IV and V controlled substances.
KM 19 (2 Credits): Systematically obtains prescription claims data in order to assess and address medication adherence
The practice systematically obtains prescription claims data or other medication transaction history. This may include systems such as SureScripts e-prescribing network, regional health information exchanges, insurers or prescription benefit management companies. The practice uses prescription claims data to determine whether a patient is adhering to the medication treatment plan.